Your search returned 1978 results.

Results
	181.	PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? [electronic resource] by Mannarino, Massimo R Sahebkar, Amirhossein Bianconi, Vanessa Serban, Maria-Corina Banach, Maciej Pirro, Matteo Producer: 20191007 In: Journal of clinical lipidology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	182.	Endocytosis of lipoproteins. [electronic resource] by Zanoni, Paolo Velagapudi, Srividya Yalcinkaya, Mustafa Rohrer, Lucia von Eckardstein, Arnold Producer: 20191023 In: Atherosclerosis vol. 275 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	183.	Review: In dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and stroke. [electronic resource] by Smith, Donald A Producer: 20200401 In: Annals of internal medicine vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	184.	PCSK9 function and physiology. [electronic resource] by Peterson, Andrew S Fong, Loren G Young, Stephen G Producer: 20080905 In: Journal of lipid research vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	185.	Role of lipoproteins and proprotein convertase subtilisin/kexin type 9 in endotoxin clearance in sepsis. [electronic resource] by Walley, Keith R Producer: 20180427 In: Current opinion in critical care vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	186.	PCSK9 Association With Lipoprotein(a). [electronic resource] by Tavori, Hagai Christian, Devon Minnier, Jessica Plubell, Deanna Shapiro, Michael D Yeang, Calvin Giunzioni, Ilaria Croyal, Mikael Duell, P Barton Lambert, Gilles Tsimikas, Sotirios Fazio, Sergio Producer: 20170428 In: Circulation research vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	187.	PCSK9 induces a pro-inflammatory response in macrophages. [electronic resource] by Ricci, Chiara Ruscica, Massimiliano Camera, Marina Rossetti, Laura Macchi, Chiara Colciago, Alessandra Zanotti, Ilaria Lupo, Maria Giovanna Adorni, Maria Pia Cicero, Arrigo F G Fogacci, Federica Corsini, Alberto Ferri, Nicola Producer: 20181211 In: Scientific reports vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	188.	Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives. [electronic resource] by Tsouka, Aikaterini N Tellis, Constantinos C Tselepis, Alexandros D Producer: 20191121 In: Current pharmaceutical design vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	189.	A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases. [electronic resource] by Chen, Bo Shi, Xin Cui, Yanping Hou, Aiping Zhao, Pengjun Producer: 20191111 In: Current topics in medicinal chemistry vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	190.	The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family. [electronic resource] by Ruotolo, Anna Di Taranto, Maria Donata D'Agostino, Maria Nicoletta Marotta, Gennaro Gentile, Marco Nunziata, Maria Sodano, Marta Di Noto, Rosa Del Vecchio, Luigi Rubba, Paolo Fortunato, Giuliana Producer: 20150206 In: Clinical chemistry and laboratory medicine vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	191.	'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. [electronic resource] by Annemans, Lieven Packard, Chris J Briggs, Andrew Ray, Kausik K Producer: 20191127 In: European heart journal vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	192.	Effect of cholesterol lowering with statins or proprotein convertase subtilisin/kexin type 9 antibodies on cataracts: A meta-analysis. [electronic resource] by Dobrzynski, Jeanne M Kostis, John B Sargsyan, Davit Zinonos, Stavros Kostis, William J Producer: 20190916 In: Journal of clinical lipidology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	193.	[Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages]. [electronic resource] by Bao, H L Liao, F J Fang, L Zhong, F Liu, W Li, J Q Producer: 20190823 In: Zhonghua xin xue guan bing za zhi vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	194.	Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors. [electronic resource] by Panagiotopoulou, Olga Chiesa, Scott T Tousoulis, Dimitrios Charakida, Marietta Producer: 20200924 In: Current medicinal chemistry vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	195.	Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins. [electronic resource] by Laufs, Ulrich Producer: 20190610 In: Cardiovascular research vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	196.	Neurocognitive Risk With PCSK9 Inhibitors: Need for More Robust Evidence. [electronic resource] by Khan, Abdur Rahman Riaz, Haris Farid, Talha Bolli, Roberto Producer: 20190520 In: Journal of the American College of Cardiology vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	197.	Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. [electronic resource] by Calandra, Sebastiano Tarugi, Patrizia Bertolini, Stefano Producer: 20171218 In: Current opinion in lipidology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	198.	Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis. [electronic resource] by Boyd, John H Fjell, Christopher D Russell, James A Sirounis, Demetrios Cirstea, Mihai S Walley, Keith R Producer: 20161213 In: Journal of innate immunity vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	199.	Antisense Oligonucleotides for Splice Modulation: Assessing Splice Switching Efficacy. [electronic resource] by Rocha, Cristina S J Producer: 20200403 In: Methods in molecular biology (Clifton, N.J.) vol. 2036 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	200.	Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way. [electronic resource] by Schlüter, Klaus-Dieter Wolf, Annemarie Weber, Martin Schreckenberg, Rolf Schulz, Rainer Producer: 20180613 In: Basic research in cardiology vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.